In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  1999-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0091-6749(99)70325-8PMID 10482829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway.

  1998cited by this paper
• Nerve Growth Factor Activates Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Pathways To Stimulate CREB Serine 133 Phosphorylation

  1998cited by this paper
• Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes.

  1998cited by this paper
• AP-1 function and regulation.

  1997cited by this paper
• Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β

  1997cited by this paper
• Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK

  1997cited by this paper
• Pathogenesis of steroid-resistant asthma.

  1997cited by this paper
• Glucocorticoid-Dependent Transcriptional Repression of the Osteocalcin Gene by Competitive Binding at the TATA Box

  1997cited by this paper
• Pathogenesis of steroid-resistant asthma.

  1997cited by this paper
• Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway.

  1997cited by this paper
• Transcriptional regulation by steroid hormones.

  1996cited by this paper
• The regulation of AP-1 activity by mitogen-activated protein kinases.

  1996cited by this paper
• Selective c-Jun overexpression is associated with ionizing radiation-induced apoptosis in the developing cerebellum of the rat.

  1996cited by this paper
• Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.

  1996cited by this paper
• Mononuclear cells in corticosteroid-resistant asthma.

  1996cited by this paper
• Regulation of transcription by MAP kinase cascades.

  1996cited by this paper
• The effects of prednisolone on the cutaneous tuberculin response in patients with corticosteroid-resistant bronchial asthma.

  1996cited by this paper
• Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

  1995cited by this paper
• Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland

  1995cited by this paper
• Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma

  1995cited by this paper
• Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma.

  1995cited by this paper
• Journey to the surface of the cell: Fos regulation and the SRE.

  1995cited by this paper
• Thyrotropin-releasing hormone and c-fos/c-jun genes are colocalized in rat anterior pituitary cells: stimulation of transcription by glucocorticoids.

  1995cited by this paper
• Inhaled glucocorticoids for asthma.

  1995cited by this paper
• Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

  1995cited by this paper
• Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.

  1994cited by this paper
• Sequence of the 5'-flanking region of the rat c-fos proto-oncogene.

  1994cited by this paper
• Negative transcriptional regulation by nuclear receptors.

  1994cited by this paper
• JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

  1994cited by this paper
• The effects of hydrocortisone on in vitro lymphocyte proliferation and interleukin‐2 and ‐4 production in corticosteroid sensitive and resistant subjects

  1993cited by this paper
• Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes.

  1992cited by this paper
• Control of transcription activation by steroid hormone receptors

  1992cited by this paper
• Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.

  1990cited by this paper
• Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival.

  1986cited by this paper
• A histochemical analysis of mononuclear cell infiltrates of the skin. II. Delayed hypersensitivity in the human.

  1966cited by this paper

• Glucocorticoid receptor signaling: crosstalk with inflammation

  2026cites this paper
• Proteomic and Transcriptomic Signatures of Poor Asthma Symptom Control in the U-BIOPRED Cohort.

  2025cites this paper
• Novel Perspectives of TSLP and RXR Signaling in Corticosteroid-Resistant Asthma: Updates on TSLP Blockers.

  2024cites this paper
• Grandmaternal allergen sensitization reprograms epigenetic and airway responses to allergen in second-generation offspring

  2023cites this paper
• The Correlation of PM2.5 Exposure with Acute Attack and Steroid Sensitivity in Asthma

  2022cites this paper
• Grandmaternal allergen exposure causes distinct epigenetic trajectories in offspring associated with airway hyperreactivity and inflammation

  2022cites this paper
• Associations of the Methylation Levels of NFAT5, PVT1, RPS6KA1, and MIB1 with Steroid-Resistant Asthma

  2022cites this paper
• Machine learning implicates the IL-18 signaling axis in severe asthma

  2021cites this paper
• The role of protein phosphorylation in the regulation of class switch recombination

  2020cites this paper
• Erythromycin reverses cigarette smoke extract-induced corticosteroid insensitivity by inhibition of the JNK/c-Jun pathway.

  2019cites this paper
• Pharmacological targeting of allergen-specific T lymphocytes.

  2017cites this paper
• Impaired Dual-Specificity Protein Phosphatase DUSP4 Reduces Corticosteroid Sensitivity

  2017cites this paper
• The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases

  2016cites this paper
• Glucocorticoid Resistant Asthma: The Potential Contribution of IL-17

  2015cites this paper
• Absence of c-Jun NH2-terminal kinase 1 protects against house dust mite-induced pulmonary remodeling but not airway hyperresponsiveness and inflammation.

  2014cites this paper
• Respiratory innate immune factors regulate steroid-resistant airway hyperreactivity and asthma

  2014cites this paper
• Role of Transcription Factors in the Pathogenesis of Asthma and COPD

  2013cites this paper
• Therapeutic Potential of Kinases in Asthma

  2013cites this paper
• Requirement of Apoptosis-Inducing Kinase 1 for the Induction of Bronchial Asthma following Stimulation with Ovalbumin

  2013cites this paper
• Novel Anti‐Inflammatory Treatments for Asthma and COPD

  2012cites this paper
• Mechanisms of Reduced Glucocorticoid Sensitivity in Bronchial Asthma

  2012cites this paper
• Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma.

  2012cites this paper
• Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation.

  2012cites this paper
• Glucocorticoids: Pharmacology and Mechanisms

  2012cites this paper
• Kinase Targets and Inhibitors for the Treatment of Airway Inflammatory Diseases

  2012cites this paper
• The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look

  2012cites this paper
• Defects of Protein Phosphatase 2A Causes Corticosteroid Insensitivity in Severe Asthma

  2011cites this paper
• Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.

  2010cites this paper
• Importance of glucocorticoid receptors in upper and lower airways.

  2010cites this paper
• Heterogeneity of Glucocorticoid Resistance in Patients with Bronchial Asthma

  2010cites this paper
• Signal Transduction Pathways Involved in Glucocorticoid Actions

  2010cites this paper
• Glucocorticoid Insensitive Asthma

  2009cites this paper
• Glucocorticoid Regulation of Mouse and Human Dual Specificity Phosphatase 1 (DUSP1) Genes

  2009cites this paper
• c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis.

  2009cites this paper
• Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

  2009cites this paper
• Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma

  2009cites this paper
• Chapter 31 – Transcription Factors

  2009cites this paper
• Corticosteroid Biology in Critical Illness: Modulatory Mechanisms and Clinical Implications

  2009cites this paper
• Role of Dual Specificity Phosphatases in Biological Responses to Glucocorticoids*

  2008cites this paper
• Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction

  2008cites this paper
• New targets for drug development in asthma.

  2008cites this paper
• Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy

  2007influential citation
• Oral corticosteroid-dependent asthma: a 30-year review.

  2007cites this paper
• Dexamethasone Does Not Inhibit Airway CXC Chemokine Expression and Neutrophilia in a Murine Model of Asthma: Mechanism of Steroid Resistance in Asthma

  2007cites this paper
• Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.

  2007cites this paper
• c-Jun N-terminal kinase-dependent mechanisms in respiratory disease

  2006cites this paper
• Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1

  2006cites this paper
• Kinase inhibitors and airway inflammation.

  2006cites this paper
• Novel signal transduction modulators for the treatment of airway diseases.

  2006cites this paper
• Corticosteroid effects on cell signalling

  2006cites this paper
• Corticosteroids: the drugs to beat.

  2006cites this paper
• Update on glucocorticoid action and resistance.

  2006cites this paper
• Targeting mitogen-activated protein kinases for asthma.

  2006cites this paper
• Dual-specificity phosphatase 1: a critical regulator of innate immune responses.

  2006cites this paper
• Corticosteroid Insensitivity in Smokers with Asthma

  2006cites this paper
• Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma.

  2006cites this paper
• Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients.

  2006cites this paper
• Keratinocytes in Atopic Eczema

  2006cites this paper
• Current perspectives Update on glucocorticoid action and resistance

  2006cites this paper
• Mitogen‐activated protein kinases and asthma

  2005cites this paper
• Asthme corticorésistant et corticodépendant : quelles solutions ?

  2005cites this paper
• Corticosteroid Resistance in COPD

  2005cites this paper
• Potential role of stem cell factor in the asthma control by glucocorticoids.

  2005cites this paper
• Targeting kinases in asthma

  2005cites this paper
• Molecular mechanisms and cellular effects of glucocorticosteroids.

  2005cites this paper
• Corticosteroid resistance in airway disease.

  2004cites this paper
• Corticosteroids: the mainstay in asthma therapy.

  2004cites this paper
• Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives.

  2004cites this paper
• Novel Anti-inflammatory Therapies

  2004cites this paper
• Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF‐AT pathway

  2004cites this paper
• New drugs for asthma

  2004cites this paper
• MECHANISMS OF STEROID ACTION AND RESISTANCE IN INFLAMMATION MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?

  2003cites this paper
• Update on glucocorticoid action and resistance.

  2003cites this paper
• 13th European Respiratory Society Annual Congress

  2003cites this paper
• Glucocorticoid suppression of nuclear factor-kappa B: a role for histone modifications.

  2003cites this paper
• The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.

  2003cites this paper
• Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases.

  2003cites this paper
• Emerging approaches to the treatment of asthma: highlights from the patents of 2001 and 2002

  2003influential citation
• MECHANISMS OF STEROID ACTION AND RESISTANCE IN INFLAMMATION Corticosteroid-insensitive asthma: molecular mechanisms

  2003cites this paper
• Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates nitric oxide-induced activator protein-1 activation in human bronchial epithelial cells.

  2003cites this paper
• Corticosteroid-insensitive asthma: molecular mechanisms.

  2003cites this paper
• Steroid-Unresponsive Asthma

  2002cites this paper
• Mast cells as targets for glucocorticoids in the treatment of allergic disorders.

  2002cites this paper
• Chapter 33 – Transcription Factors

  2002cites this paper
• Association of Galectin-9 with Eosinophil Apoptosis

  2002cites this paper
• Expression of c-fos, rather than c-jun or glucocorticoid-receptor mRNA, correlates with decreased glucocorticoid response of peripheral blood mononuclear cells in asthma.

  2002cites this paper
• Refractory asthma.

  2002cites this paper
• New Glucocorticosteroids with an improved therapeutic ratio?

  2001cites this paper
• GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.

  2001cites this paper
• Glucocorticoid-regulated transcription factors.

  2001cites this paper
• Cross‐talk between pro‐inflammatory transcription factors and glucocorticoids

  2001cites this paper
• Steroid-Resistant Asthma: New Insights and Implications for Management

  2001cites this paper
• Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells.

  2001cites this paper
• Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform.

  2000cites this paper
• Is there a role for glucocorticoid receptor beta in glucocorticoid-dependent asthmatics?

  2000cites this paper
• Is there a role for glucocorticoid receptor beta in glucocorticoid-dependent asthmatics?

  2000cites this paper
• Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society.

  2000cites this paper
• Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform

  2000cites this paper
• Heterogeneity of therapeutic responses in asthma.

  2000cites this paper
• Presentation at the National Asthma Campaign International Congress, June 1999Controlling the inflammatory response through transcriptional mechanisms

  2000cites this paper